Endothelial dysfunction in diabetes
Tóm tắt
Endothelial dysfunction plays a key role in the pathogenesis of diabetic vascular disease. The endothelium controls the tone of the underlying vascular smooth muscle through the production of vasodilator mediators. The endothelium‐derived relaxing factors (EDRF) comprise nitric oxide (NO), prostacyclin, and a still elusive endothelium‐derived hyperpolarizing factor (EDHF). Impaired endothelium‐dependent vasodilation has been demonstrated in various vascular beds of different animal models of diabetes and in humans with type 1 and 2 diabetes. Several mechanisms of endothelial dysfunction have been reported, including impaired signal transduction or substrate availibility, impaired release of EDRF, increased destruction of EDRF, enhanced release of endothelium‐derived constricting factors and decreased sensitivity of the vascular smooth muscle to EDRF. The principal mediators of hyperglycaemia‐induced endothelial dysfunction may be activation of protein kinase C, increased activity of the polyol pathway, non‐enzymatic glycation and oxidative stress. Correction of these pathways, as well as administration of ACE inhibitors and folate, has been shown to improve endothelium‐dependent vasodilation in diabetes. Since the mechanisms of endothelial dysfunction appear to differ according to the diabetic model and the vascular bed under study, it is important to select clinically relevant models for future research of endothelial dysfunction.
Từ khóa
Tài liệu tham khảo
BOHLEN H.G., 1993, Topical hyperglycemia rapidly suppresses EDRF‐mediated vasodilation of normal rat arterioles, Am. J. Physiol., 265, H219
BOHLEN H.G., 1995, Endothelium‐dependent vasodilation is preserved in non‐insulin‐dependent Zucker fatty diabetic rats, Am. J. Physiol., 268, H2366
CERIELLO A., 1999, Hyperglycemia: the bridge between non‐enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications, Diabetes Nutr. Metab., 12, 42
DAI F., 1993, Diabetes‐induced endothelial dysfunction in streptozotocin‐treated rats: role of prostaglandin endoperoxides and free radicals, J. Am. Soc. Nephrol., 4, 1327, 10.1681/ASN.V461327
DE VRIESE A., 1999, Impaired endothelium‐derived hyperpolarizing factormediated renal vasodilatory response in diabetes: restoration with folate, J. Am. Soc. Nephrol., 10, 394A
DIEDERICH D., 1994, Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals, Am. J. Physiol., 266, H1153
FRIEDMAN E.A., 1999, Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications, Diabetes Care, 22, B65
FULTON D., 1996, Cytochrome P450 arachidonate metabolites: deficit in diabetes mellitus, FASEB J., 9, A113
HATTORI Y., 1991, Superoxide dismutase recovers altered endothelium‐dependent relaxation in diabetic rat aorta, Am. J. Physiol., 261, H1086
HILL M.A., 1994, Active and passive mechanical properties of isolated arterioles from STZ‐induced diabetic rats. Effect of aminoguanidine treatment, Diabetes, 43, 1450, 10.2337/diab.43.12.1450
KATUSIC Z.S., 1989, Superoxide anion is an endothelium‐derived contracting factor, Am. J. Physiol., 257, H33
MAYHAN W.G., 1993, Responses of cerebral arterioles in diabetic rats to activation of ATP‐sensitive potassium channels, Am. J. Physiol., 265, H152
MAYHAN W.G., 1995, Acute effects of glucose on reactivity of cerebral microcirculation: role of activation of protein kinase C, Am. J. Physiol., 269, H1297
MAYHAN W.G., 1991, Mechanisms of impaired responses of cerebral arterioles during diabetes mellitus, Am. J. Physiol., 260, H319
NITENBERG A., 1993, Impairment of coronary vascular reserve and ACh‐induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function, Diabetes, 42, 1017, 10.2337/diab.42.7.1017
PIEPER G.M., 1988, Oxygen free radicals abolish endothelium‐dependent relaxation in diabetic aorta, Am. J. Physiol., 255, H825
QUILLEY J., 1996, NO‐independent coronary vasodilation to bradykinin in diabetes, Hypertension, 28, P178
SAKAMOTO S., 1998, Effect of exercise training and food restriction on endothelium‐dependent relaxation in the Otsuka Long‐Evans Tokushima Fatty rat, a model of spontaneous NIDDM, Diabetes, 47, 82, 10.2337/diab.47.1.82
SMITS P., 1993, Endothelium‐dependent vascular relaxation in patients with type I diabetes, Diabetes, 42, 148, 10.2337/diab.42.1.148
TESFAMARIAM B., 1989, Contraction of diabetic rabbit aorta caused by endothelium‐derived PGH2‐TxA2, Am. J. Physiol., 257, H1327
THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP/EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS RESEARCH GROUP(2000).Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.N. Eng. J. Med. 342 381–389.
TILTON R.G., 1993, Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end‐product formation, Diabetes, 42, 221, 10.2337/diab.42.2.221
WANG Y., 1993, Attenuated glomerular cGMP production and renal vasodilation in streptozotocin‐induced diabetic rats, Am. J. Physiol., 264, R952
YAN S.D., 1994, Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins, J. Cell. Biol., 269, 9889
ZENON G.J., 1990, Potential use of aldose reductase inhibitors to prevent diabetic complications, Clin. Pharm., 9, 446